Search Results - "Uster, Anastasia"

Development and validation of a chronic kidney disease progression model using patient-level simulations by Ramos, Mafalda, Gerlier, Laetitia, Uster, Anastasia, Muttram, Louise, Steubl, Dominik, Frankel, Andrew H, Lamotte, Mark

“…Chronic disease progression models are available for several highly prevalent conditions. For chronic kidney disease (CKD), the scope of existing progression…”
Get full text

CKD Progression Model (CKD-PM): Development and Validation: FR-PO940 by Uster, Anastasia, Ramos, Mafalda, Gerlier, Laetitia, Muttram, Louise E., Steubl, Dominik, Frankel, Andrew H., Lamotte, Mark

Get full text

Effect of empagliflozin on all-cause hospitalization in EMPA-KIDNEY by Uster, Anastasia, Desai, Nihar, Navaneethan, Sankar, Pfarr, Egon, Mazo, Anna Rita

Get full text

Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom by Ramos, Mafalda, Gerlier, Laetitia, Uster, Anastasia, Muttram, Louise, Frankel, Andrew H, Lamotte, Mark

“…The sodium-glucose co-transporter-2 inhibitor empagliflozin was approved for treatment of adults with chronic kidney disease (CKD) on the basis of its…”
Get more information

Treatment with dual agonist improves eating behaviour in people living with overweight/obesity by Ekinci, Elif, Bushnell, Donald M, Le Roux, Carel W, Steen, Oren, Lucas, Kathyrn J, Brod, Meryl, Roberts, Carl A, Startseva, Elena, Unseld, Anna, Uster, Anastasia

Get full text

31 - Treatment with dual agonist improves eating behaviour in people living with overweight/obesity by Ekinci, Elif, Bushnell, Donald M, Le Roux, Carel W, Steen, Oren, Lucas, Kathyrn J, Brod, Meryl, Roberts, Carl A, Startseva, Elena, Unseld, Anna, Uster, Anastasia

Get full text